Author

Jing Xiao

Texas A&M University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Biology Disciplines

Click to filter author papers

Biochemistry· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Benjamin W. NeumaniD· 1 shared Demonta D. ColemaniD· 1 shared Kaustav KhatuaiD· 1 shared Lauren R. BlankenshipiD· 1 shared Long SuniD· 1 shared Sandeep AtlaiD· 1 shared Sathish KumariD· 1 shared Shiqing XuiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBiochemistry

Benjamin W. NeumanORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

BiochemistryJournal of Medicinal ChemistryPeer-reviewedApr 12, 2024

Discovery of First-in-Class PROTAC Degraders of SARS-CoV-2 Main Protease

Yugendar R. Alugubelli, Jing Xiao, Kaustav Khatua…·Shiqing Xu

This paper develops first-in-class PROTAC degraders of SARS-CoV-2 main protease, showing they reduce MPro levels and exhibit anti-SARS-CoV-2 activity.

89 citationstop 1%

experimental assaydrug response / drug discovery

𝕏 PostBluesky